Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin powder for prevention of infection in spine surgery
NCT03883022Recruiting
- Sponsor
- Taipei Veterans General Hospital
- Start
- Sep 2018
- Primary completion
- Sep 2027
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of vancomycin in surgical site infection (SSI), sponsored by Taipei Veterans General Hospital. Primary endpoints: Bony fusion status at 1 year and Functional outcomes at 1 year. Started Sep 2018; status: recruiting.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03883022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883022.